Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $48

Keybanc analyst Matthew Mishan maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $47 to $48.

November 4, 2022

1 minute read

Keybanc analyst Matthew Mishan maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $47 to $48.

Netflix Announced Start of Production of Romain Gavras’ Currently Untitled New Film

Today, 5:50 AM

https://about.netflix.com/en/news/romain-gavras-new-film-for-netflix-starts-production-in-france

Today, 5:50 AM

The Power of the Dividend

Today, 5:50 AM

Wolfe Research analyst Steven Chubak upgrades Bank of New York Mellon (NYSE:BK) from Peer Perform to Outperform and announces $60 price target.

Today, 5:50 AM

Resonate Blends, Inc. (OTCQB: KOAN), has teamed with Nabis, on statewide distribution of its Koan Cordial line.